News – Page 1033 – Endpoints News

Ex-con Sam Waksal's startup prices IPO, joining parade of biotechs with Nasdaq news

7 years ago

Sound familiar? China/US biotech hybrid lands rights to cancer drugs, cash and a team of development vets to launch ...

7 years ago

Diabetes giant Novo said to consider up to 3,000 layoffs as US pricing storms gather: report

7 years ago

Relocating its US HQ to Boston, French pharma Ipsen to add 250 jobs

7 years ago

Gates Foundation sets up biotech-like institute in hands-on effort to spur drug development for neglected diseases

7 years ago

Proteostasis shares whacked hard as CF drug falls short; Advaxis axes trial plans in wake of a clinical hold

7 years ago

On an executive hiring spree, Sarepta snags Biogen's Gilmore O'Neill as new CMO

7 years ago

That big Biogen deal you were waiting for? Keep waiting

7 years ago

Mega-blockbuster? Pfizer lines up for a snap review of its PARP drug talazoparib — and a launch into a crowded ...

7 years ago

Notorious activist investor Carl Icahn buys small stake in Allergan

7 years ago

Tilting at vaccines giants, SutroVax fuels up on a $170M-plus quest to vault past the world's best-selling vaccine

7 years ago

Manufacturing experts at Hangzhou Just Biotherapeutics bank $35M for stealthy R&D in China and the US

7 years ago

Biogen, Eisai BACE drug cuts amyloid beta in the brain, but there’s no hard data to show it does anything important ...

7 years ago

Eyeing NDA for its diabetes drug, Hua Medicine knocks at HKEX's door with an IPO application

7 years ago

Swiss attorney general isn't prosecuting Novartis for bribery; Madrigal to raise $200M in stock sale

7 years ago

Rich Heyman's Metacrine tacks on another $65M to tackle a superior NASH drug

7 years ago

Pfizer adds $600M to its venture group, with a special focus on the neurosciences field it just retreated from

7 years ago

Clinical trial disruptor Science 37 in talks with SoftBank on a $150M investment — Recode

7 years ago

Genentech dives deeper into the microbiome, inking $534M deal with Microbiotica to develop IBD meds

7 years ago

Scientists set out to build an ultra-fast camera to capture effect of new cancer drug tech

7 years ago

FDA vet — and Woodcock nemesis — John Jenkins is stepping over to a new role as a board member at Corbus Pharma

7 years ago

Picking up the pieces left from an Alzheimer’s implosion, Axovant is starting over by diving into gene therapy

7 years ago

Gilead ups its bet on HIV, hep B, inking $400M partnership with immunotherapy company Hookipa

7 years ago

Roche gets priority review for Hemlibra's second indication; Orasis gets $13M B round for presbyopia eye drop

7 years ago

First page Previous page 1030 1031 103210331034 1035 1036 Next page Last page